Table 2.
Subject characteristics at baseline1,2
| Dose at randomization | ||
|---|---|---|
| 21 g | 42 g | |
| Age, y | 64.8 ± 7.8 | 56.6 ± 13.9 |
| BMI, kg/m2 | 27.3 ± 3.6 | 27.4 ± 3.8 |
| Female, % (n) | 55 (6) | 60 (6) |
| Male, % (n) | 45 (5) | 40 (4) |
| Systolic BP, mm Hg | 109 ± 7 | 116 ± 14 |
| Diastolic BP, mm Hg | 73 ± 10 | 72 ± 10 |
| TC, mmol/L | 5.49 ± 1.17 | 5.54 ± 1.06 |
| LDL, mmol/L | 3.37 ± 0.96 | 3.50 ± 0.91 |
| HDL, mmol/L | 1.61 ± 0.44 | 1.48 ± 0.18 |
| Triglycerides, mmol/L | 1.21 ± 0.40 | 1.24 ± 0.53 |
| Total carotenoids, μmol/L | 2.2 ± 1.0 | 2.6 ± 1.2 |
| α-tocopherol, μmol/L | 26.4 ± 6.8 | 29.3 ± 7.1 |
| γ-tocopherol, μmol/L | 5.4 ± 3.1 | 4.4 ± 2.7 |
| Vitamin C, μmol/L | 48.3 ± 21.0 | 60.8 ± 30.1 |
| Folate, nmol/L | 56.0 ± 17.2 | 50.1 ± 17.4 |
| PLP, nmol/L | 44.6 ± 17.7 | 67.8 ± 59.7 |
1No significant between-group differences were detected using the independent samples t-test (continuous variables) or chi-square test (categorical variables).
2Values are means ± SD or n (%)